An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation show a high response to EGFR-tyrosine kinase inhibitor (EGFR-TKI). Clinically, EGFR-positive NSCLC acquires several resistance mechanisms during EGFR-TKI treatment, such as the emergence of a secondary...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Yoshimura, Akihiro, Uchino, Junji, Tanimura, Keiko, Chihara, Yusuke, Tamiya, Nobuyo, Kaneko, Yoshiko, Takeda, Takayuki, Hiranuma, Osamu, Hasegawa, Isao, Kubota, Yutaka, Shiotsu, Shinsuke, Takumi, Chieko, Hiraoka, Noriya, Yamada, Tadaaki, Takayama, Koichi
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6200532/
https://ncbi.nlm.nih.gov/pubmed/30290647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars